These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9162203)
1. Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT(1A) receptors in ventral prefrontal cortex in schizophrenia. Simpson MD; Lubman DI; Slater P; Deakin JF Biol Psychiatry; 1996 Jun; 39(11):919-28. PubMed ID: 9162203 [TBL] [Abstract][Full Text] [Related]
2. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Burnet PW; Eastwood SL; Harrison PJ Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998 [TBL] [Abstract][Full Text] [Related]
3. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study. Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431 [TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. Meller E; Li H; Carr KD; Hiller JM J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306 [TBL] [Abstract][Full Text] [Related]
5. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723 [TBL] [Abstract][Full Text] [Related]
7. Central 5-HT(1) and 5-HT(2) binding sites in transgenic mice with reduced glucocorticoid receptor number. Farisse J; Héry F; Barden N; Héry M; Boulenguez P Brain Res; 2000 Apr; 862(1-2):145-53. PubMed ID: 10799679 [TBL] [Abstract][Full Text] [Related]
8. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Hashimoto T; Nishino N; Nakai H; Tanaka C Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Casanovas JM; Vilaró MT; Mengod G; Artigas F J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078 [TBL] [Abstract][Full Text] [Related]
10. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Sumiyoshi T; Stockmeier CA; Overholser JC; Dilley GE; Meltzer HY Brain Res; 1996 Feb; 708(1-2):209-14. PubMed ID: 8720882 [TBL] [Abstract][Full Text] [Related]
11. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620 [TBL] [Abstract][Full Text] [Related]
12. The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. Calcagno E; Carli M; Invernizzi RW J Neurochem; 2006 Feb; 96(3):853-60. PubMed ID: 16405507 [TBL] [Abstract][Full Text] [Related]
13. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Arango V; Underwood MD; Boldrini M; Tamir H; Kassir SA; Hsiung S; Chen JJ; Mann JJ Neuropsychopharmacology; 2001 Dec; 25(6):892-903. PubMed ID: 11750182 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Burnet PW; Eastwood SL; Harrison PJ Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117 [TBL] [Abstract][Full Text] [Related]
15. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues. Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719 [TBL] [Abstract][Full Text] [Related]
16. Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors. Pauwels PJ; Dupuis DS; Perez M; Halazy S Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):404-10. PubMed ID: 9826061 [TBL] [Abstract][Full Text] [Related]
17. Regional CNS densities of serotonin 1A and dopamine D2 receptors in periadolescent alcohol-preferring P and alcohol-nonpreferring NP rat pups. Strother WN; Lumeng L; Li TK; McBride WJ Pharmacol Biochem Behav; 2003 Jan; 74(2):335-42. PubMed ID: 12479952 [TBL] [Abstract][Full Text] [Related]
18. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors. Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924 [TBL] [Abstract][Full Text] [Related]
19. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. Ichikawa J; Meltzer HY J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846 [TBL] [Abstract][Full Text] [Related]
20. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain. Barone P; Jordan D; Atger F; Kopp N; Fillion G Brain Res; 1994 Feb; 638(1-2):85-94. PubMed ID: 8199879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]